Balt’s Squid™ Liquid Embolic Receives FDA Approval for Adjunctive Treatment for ...

Balt, Inc., a global technology leader in neurovascular devices, today announced the Premarket Approval (PMA) of the Squid™ ...

Balt Group: Balt's Squid Liquid Embolic Receives FDA Approval for Adjunctive Treatment for ...

Balt, Inc., a global technology leader in neurovascular devices, today announced the Premarket Approval (PMA) of the Squid liquid embolic agent. Squid is approved ...
Seeking Alpha

Johnson & Johnson Receives FDA Approval for TRUFILL n‑BCA Liquid Embolic System for the ...

- TRUFILL n-BCA is now indicated for embolization of the middle meningeal artery (MMA) for the treatment of symptomatic subacute and Chronic Subdural Hematoma (cSDH) as an adjunct to surgery. - ...
Nasdaq

FDA Approves Expanded Use Of Johnson & Johnson's TRUFILL N-BCA For Subdural Hematoma

(RTTNews) - Johnson & Johnson MedTech, the medical technology arm of Johnson & Johnson (J&J) on Thursday said the U.S. Food and Drug Administration (FDA) has approved an expanded indication for its ...
Morningstar

Johnson & Johnson Receives FDA Approval for TRUFILL n‑BCA Liquid Embolic System for the ...

- TRUFILL n-BCA is now indicated for embolization of the middle meningeal artery (MMA) for the treatment of symptomatic subacute and Chronic Subdural Hematoma (cSDH) as an adjunct to surgery. - ...